- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Gabapentin Enacarbil market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Gabapentin Enacarbil market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of XX%% in the forecast period of 2020 to 2025 and will expected to reach USD XX million by 2025, from USD XX million in 2019.
Market segmentation
Gabapentin Enacarbil market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Gabapentin Enacarbil market has been segmented into Capsule, Tablet, etc.
Breakdown by Application, Gabapentin Enacarbil has been segmented into Post-Herpetic Neuralgia (PHN), Restless Legs Syndrome (RLS), Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gabapentin Enacarbil market presented in the report. This section sheds light on the sales growth of different regional and country-level Gabapentin Enacarbil markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gabapentin Enacarbil market.
For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Gabapentin Enacarbil Market Share Analysis
Gabapentin Enacarbil competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Gabapentin Enacarbil sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gabapentin Enacarbil sales, revenue and market share for each player covered in this report.
The major players covered in Gabapentin Enacarbil are: Arbor Pharma, Mylan, Glenmark Pharma, Astellas, Teva, GlaxoSmithKline, Apotex, Depomed, Pfizer, Novartis, Marksans Pharma, Jiangsu Hengrui, Sun Pharmaceutical, Alkem, Amneal, Aurobindo Pharma, Sailike Pharma, Jiangsu Enhua, Intas, etc. Among other players domestic and global, Gabapentin Enacarbil market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Gabapentin Enacarbil market are listed below:
Arbor Pharma
Mylan
Glenmark Pharma
Astellas
Teva
GlaxoSmithKline
Apotex
Depomed
Pfizer
Novartis
Marksans Pharma
Jiangsu Hengrui
Sun Pharmaceutical
Alkem
Amneal
Aurobindo Pharma
Sailike Pharma
Jiangsu Enhua
Intas
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Capsule
Tablet
Market segment by Application, can be divided into
Post-Herpetic Neuralgia (PHN)
Restless Legs Syndrome (RLS)
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Gabapentin Enacarbil Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gabapentin Enacarbil Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Capsule
1.2.3 Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Gabapentin Enacarbil Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Post-Herpetic Neuralgia (PHN)
1.3.3 Restless Legs Syndrome (RLS)
1.3.4 Others
1.4 Global Gabapentin Enacarbil Market Size and Forecast (2015-2025)
1.4.1 Global Gabapentin Enacarbil Revenue and Forecast (2015-2025)
1.4.2 Global Gabapentin Enacarbil Sales and Forecast (2015-2025)
1.5 Global Gabapentin Enacarbil Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Arbor Pharma
2.1.1 Arbor Pharma Details
2.1.2 Arbor Pharma Major Business
2.1.3 Arbor Pharma SWOT Analysis
2.1.4 Arbor Pharma Product and Services
2.1.5 Arbor Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Glenmark Pharma
2.3.1 Glenmark Pharma Details
2.3.2 Glenmark Pharma Major Business
2.3.3 Glenmark Pharma SWOT Analysis
2.3.4 Glenmark Pharma Product and Services
2.3.5 Glenmark Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Astellas
2.4.1 Astellas Details
2.4.2 Astellas Major Business
2.4.3 Astellas SWOT Analysis
2.4.4 Astellas Product and Services
2.4.5 Astellas Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva
2.5.1 Teva Details
2.5.2 Teva Major Business
2.5.3 Teva SWOT Analysis
2.5.4 Teva Product and Services
2.5.5 Teva Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Product and Services
2.6.4 GlaxoSmithKline Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Apotex
2.7.1 Apotex Details
2.7.2 Apotex Major Business
2.7.3 Apotex Product and Services
2.7.4 Apotex Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Depomed
2.8.1 Depomed Details
2.8.2 Depomed Major Business
2.8.3 Depomed Product and Services
2.8.4 Depomed Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Product and Services
2.9.4 Pfizer Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Product and Services
2.10.4 Novartis Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Marksans Pharma
2.11.1 Marksans Pharma Details
2.11.2 Marksans Pharma Major Business
2.11.3 Marksans Pharma Product and Services
2.11.4 Marksans Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Jiangsu Hengrui
2.12.1 Jiangsu Hengrui Details
2.12.2 Jiangsu Hengrui Major Business
2.12.3 Jiangsu Hengrui Product and Services
2.12.4 Jiangsu Hengrui Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Sun Pharmaceutical
2.13.1 Sun Pharmaceutical Details
2.13.2 Sun Pharmaceutical Major Business
2.13.3 Sun Pharmaceutical Product and Services
2.13.4 Sun Pharmaceutical Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Alkem
2.14.1 Alkem Details
2.14.2 Alkem Major Business
2.14.3 Alkem Product and Services
2.14.4 Alkem Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Amneal
2.15.1 Amneal Details
2.15.2 Amneal Major Business
2.15.3 Amneal Product and Services
2.15.4 Amneal Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Aurobindo Pharma
2.16.1 Aurobindo Pharma Details
2.16.2 Aurobindo Pharma Major Business
2.16.3 Aurobindo Pharma Product and Services
2.16.4 Aurobindo Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Sailike Pharma
2.17.1 Sailike Pharma Details
2.17.2 Sailike Pharma Major Business
2.17.3 Sailike Pharma Product and Services
2.17.4 Sailike Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Jiangsu Enhua
2.18.1 Jiangsu Enhua Details
2.18.2 Jiangsu Enhua Major Business
2.18.3 Jiangsu Enhua Product and Services
2.18.4 Jiangsu Enhua Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Intas
2.19.1 Intas Details
2.19.2 Intas Major Business
2.19.3 Intas Product and Services
2.19.4 Intas Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Gabapentin Enacarbil Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Gabapentin Enacarbil Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Gabapentin Enacarbil Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: China
3.2.1 Key Players Gabapentin Enacarbil Sales in China (2018-2019)
3.2.2 China Gabapentin Enacarbil Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gabapentin Enacarbil Manufacturer Market Share in 2019
3.3.2 Top 6 Gabapentin Enacarbil Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Gabapentin Enacarbil Market Size by Geography (2015-2020)
4.1.1 Global Gabapentin Enacarbil Sales by Geography (2015-2020)
4.1.2 Global Gabapentin Enacarbil Revenue by Regions (2015-2020)
4.2 Global Gabapentin Enacarbil Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Gabapentin Enacarbil Sales and Forecast by Regions (2020-2025)
4.2.2 Global Gabapentin Enacarbil Revenue and Forecast by Regions (2020-2025)
4.3 North America Gabapentin Enacarbil Market Size and Forecast (2015-2025)
4.4 Europe Gabapentin Enacarbil Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Gabapentin Enacarbil Market Size and Forecast (2015-2025)
4.6 South America Gabapentin Enacarbil Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Gabapentin Enacarbil Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Gabapentin Enacarbil Market Size by Country (2015-2020)
5.1.1 North America Gabapentin Enacarbil Sales and Market Share by Country (2015-2020)
5.1.2 North America Gabapentin Enacarbil Revenue and Market Share by Country (2015-2020)
5.2 North America Gabapentin Enacarbil Market Size and Forecast by Country (2020-2025)
5.2.1 North America Gabapentin Enacarbil Sales and Forecast by Country (2020-2025)
5.2.2 North America Gabapentin Enacarbil Revenue and Forecast by Country (2020-2025)
5.3 United States Gabapentin Enacarbil Market Size and Forecast (2015-2025)
5.4 Canada Gabapentin Enacarbil Market Size and Forecast (2015-2025)
5.5 Mexico Gabapentin Enacarbil Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Gabapentin Enacarbil Market Size by Country (2015-2020)
6.1.1 Europe Gabapentin Enacarbil Sales by Country (2015-2020)
6.1.2 Europe Gabapentin Enacarbil Revenue by Country (2015-2020)
6.2 Europe Gabapentin Enacarbil Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Gabapentin Enacarbil Sales and Forecast by Country (2020-2025)
6.2.2 Europe Gabapentin Enacarbil Revenue and Forecast by Country (2020-2025)
6.3 Germany Gabapentin Enacarbil Market Size and Forecast (2015-2025)
6.4 United Kingdom Gabapentin Enacarbil Market Size and Forecast (2015-2025)
6.5 France Gabapentin Enacarbil Market Size and Forecast (2015-2025)
6.6 Russia Gabapentin Enacarbil Market Size and Forecast (2015-2025)
6.7 Italy Gabapentin Enacarbil Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gabapentin Enacarbil Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Gabapentin Enacarbil Sales by Region (2015-2020)
7.1.2 Asia-Pacific Gabapentin Enacarbil Revenue by Region (2015-2020)
7.2 Asia-Pacific Gabapentin Enacarbil Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Gabapentin Enacarbil Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Gabapentin Enacarbil Revenue and Forecast by Region (2020-2025)
7.3 China Gabapentin Enacarbil Market Size and Forecast (2015-2025)
7.4 Japan Gabapentin Enacarbil Market Size and Forecast (2015-2025)
7.5 Korea Gabapentin Enacarbil Market Size and Forecast (2015-2025)
7.6 India Gabapentin Enacarbil Market Size and Forecast (2015-2025)
7.7 Southeast Asia Gabapentin Enacarbil Market Size and Forecast (2015-2025)
7.8 Australia Gabapentin Enacarbil Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Gabapentin Enacarbil Market Size by Country (2015-2020)
8.1.1 South America Gabapentin Enacarbil Sales by Country (2015-2020)
8.1.2 South America Gabapentin Enacarbil Revenue by Country (2015-2020)
8.2 South America Gabapentin Enacarbil Market Size and Forecast by Country (2020-2025)
8.2.1 South America Gabapentin Enacarbil Sales and Forecast by Country (2020-2025)
8.2.2 South America Gabapentin Enacarbil Revenue and Forecast by Country (2020-2025)
8.3 Brazil Gabapentin Enacarbil Market Size and Forecast (2015-2025)
8.4 Argentina Gabapentin Enacarbil Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gabapentin Enacarbil Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Gabapentin Enacarbil Sales by Country (2015-2020)
9.1.2 Middle East & Africa Gabapentin Enacarbil Revenue by Country (2015-2020)
9.2 Middle East & Africa Gabapentin Enacarbil Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Gabapentin Enacarbil Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Gabapentin Enacarbil Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Gabapentin Enacarbil Market Size and Forecast (2015-2025)
9.4 Turkey Gabapentin Enacarbil Market Size and Forecast (2015-2025)
9.5 Egypt Gabapentin Enacarbil Market Size and Forecast (2015-2025)
9.6 South Africa Gabapentin Enacarbil Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Gabapentin Enacarbil Market Size by Type (2015-2020)
10.1.1 Global Gabapentin Enacarbil Sales by Type (2015-2020)
10.1.2 Global Gabapentin Enacarbil Revenue by Type (2015-2020)
10.1.3 Global Gabapentin Enacarbil Price by Type (2015-2020)
10.2 Global Gabapentin Enacarbil Market Size and Forecast by Type (2020-2025)
10.2.1 Global Gabapentin Enacarbil Sales and Forecast by Type (2020-2025)
10.2.2 Global Gabapentin Enacarbil Revenue and Forecast by Type (2020-2025)
10.2.3 Global Gabapentin Enacarbil Price and Forecast by Type (2020-2025)
10.3 China Gabapentin Enacarbil Market Size and Forecast by Type (2015-2025)
10.3.1 China Gabapentin Enacarbil Market Size by Type (2015-2020)
10.3.2 China Gabapentin Enacarbil Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Gabapentin Enacarbil Market Size by Application (2015-2020)
11.1.1 Global Gabapentin Enacarbil Sales by Application (2015-2020)
11.1.2 Global Gabapentin Enacarbil Revenue by Application (2015-2020)
11.1.3 Global Gabapentin Enacarbil Price by Application (2015-2020)
11.2 Global Gabapentin Enacarbil Market Size and Forecast by Application (2020-2025)
11.2.1 Global Gabapentin Enacarbil Sales and Forecast by Application (2020-2025)
11.2.2 Global Gabapentin Enacarbil Revenue and Forecast by Application (2020-2025)
11.2.3 Global Gabapentin Enacarbil Price and Forecast by Application (2020-2025)
11.3 China Gabapentin Enacarbil Market Size and Forecast by Application (2015-2025)
11.3.1 China Gabapentin Enacarbil Market Size by Application (2015-2020)
11.3.2 China Gabapentin Enacarbil Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Gabapentin Enacarbil Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gabapentin Enacarbil by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gabapentin Enacarbil Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Gabapentin Enacarbil Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Global Gabapentin Enacarbil Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Arbor Pharma Basic Information, Manufacturing Base and Competitors
Table 7. Arbor Pharma Gabapentin Enacarbil Major Business
Table 8. Arbor Pharma Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 9. Arbor Pharma SWOT Analysis
Table 10. Arbor Pharma Gabapentin Enacarbil Product and Services
Table 11. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 12. Mylan Basic Information, Manufacturing Base and Competitors
Table 13. Mylan Gabapentin Enacarbil Major Business
Table 14. Mylan Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 15. Mylan SWOT Analysis
Table 16. Mylan Gabapentin Enacarbil Product and Services
Table 17. Mylan Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 18. Glenmark Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Glenmark Pharma Gabapentin Enacarbil Major Business
Table 20. Glenmark Pharma Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 21. Glenmark Pharma SWOT Analysis
Table 22. Glenmark Pharma Gabapentin Enacarbil Product and Services
Table 23. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 24. Astellas Basic Information, Manufacturing Base and Competitors
Table 25. Astellas Gabapentin Enacarbil Major Business
Table 26. Astellas Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 27. Astellas SWOT Analysis
Table 28. Astellas Gabapentin Enacarbil Product and Services
Table 29. Astellas Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 30. Teva Basic Information, Manufacturing Base and Competitors
Table 31. Teva Gabapentin Enacarbil Major Business
Table 32. Teva Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 33. Teva SWOT Analysis
Table 34. Teva Gabapentin Enacarbil Product and Services
Table 35. Teva Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 36. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 37. GlaxoSmithKline Gabapentin Enacarbil Major Business
Table 38. GlaxoSmithKline Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 39. GlaxoSmithKline SWOT Analysis
Table 40. GlaxoSmithKline Gabapentin Enacarbil Product and Services
Table 41. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 42. Apotex Basic Information, Manufacturing Base and Competitors
Table 43. Apotex Gabapentin Enacarbil Major Business
Table 44. Apotex Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 45. Apotex SWOT Analysis
Table 46. Apotex Gabapentin Enacarbil Product and Services
Table 47. Apotex Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 48. Depomed Basic Information, Manufacturing Base and Competitors
Table 49. Depomed Gabapentin Enacarbil Major Business
Table 50. Depomed Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 51. Depomed SWOT Analysis
Table 52. Depomed Gabapentin Enacarbil Product and Services
Table 53. Depomed Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 54. Pfizer Basic Information, Manufacturing Base and Competitors
Table 55. Pfizer Gabapentin Enacarbil Major Business
Table 56. Pfizer Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 57. Pfizer SWOT Analysis
Table 58. Pfizer Gabapentin Enacarbil Product and Services
Table 59. Pfizer Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 60. Novartis Basic Information, Manufacturing Base and Competitors
Table 61. Novartis Gabapentin Enacarbil Major Business
Table 62. Novartis Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 63. Novartis SWOT Analysis
Table 64. Novartis Gabapentin Enacarbil Product and Services
Table 65. Novartis Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 66. Marksans Pharma Basic Information, Manufacturing Base and Competitors
Table 67. Marksans Pharma Gabapentin Enacarbil Major Business
Table 68. Marksans Pharma Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 69. Marksans Pharma SWOT Analysis
Table 70. Marksans Pharma Gabapentin Enacarbil Product and Services
Table 71. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 72. Jiangsu Hengrui Basic Information, Manufacturing Base and Competitors
Table 73. Jiangsu Hengrui Gabapentin Enacarbil Major Business
Table 74. Jiangsu Hengrui Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 75. Jiangsu Hengrui SWOT Analysis
Table 76. Jiangsu Hengrui Gabapentin Enacarbil Product and Services
Table 77. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 78. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. Sun Pharmaceutical Gabapentin Enacarbil Major Business
Table 80. Sun Pharmaceutical Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 81. Sun Pharmaceutical SWOT Analysis
Table 82. Sun Pharmaceutical Gabapentin Enacarbil Product and Services
Table 83. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 84. Alkem Basic Information, Manufacturing Base and Competitors
Table 85. Alkem Gabapentin Enacarbil Major Business
Table 86. Alkem Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 87. Alkem SWOT Analysis
Table 88. Alkem Gabapentin Enacarbil Product and Services
Table 89. Alkem Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 90. Amneal Basic Information, Manufacturing Base and Competitors
Table 91. Amneal Gabapentin Enacarbil Major Business
Table 92. Amneal Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 93. Amneal SWOT Analysis
Table 94. Amneal Gabapentin Enacarbil Product and Services
Table 95. Amneal Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 96. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 97. Aurobindo Pharma Gabapentin Enacarbil Major Business
Table 98. Aurobindo Pharma Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 99. Aurobindo Pharma SWOT Analysis
Table 100. Aurobindo Pharma Gabapentin Enacarbil Product and Services
Table 101. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 102. Sailike Pharma Basic Information, Manufacturing Base and Competitors
Table 103. Sailike Pharma Gabapentin Enacarbil Major Business
Table 104. Sailike Pharma Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 105. Sailike Pharma SWOT Analysis
Table 106. Sailike Pharma Gabapentin Enacarbil Product and Services
Table 107. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 108. Jiangsu Enhua Gabapentin Enacarbil Type and Application
Table 109. Jiangsu Enhua Gabapentin Enacarbil Major Business
Table 110. Jiangsu Enhua Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 111. Jiangsu Enhua SWOT Analysis
Table 112. Jiangsu Enhua Gabapentin Enacarbil Product and Services
Table 113. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 114. Intas Basic Information, Manufacturing Base and Competitors
Table 115. Intas Gabapentin Enacarbil Major Business
Table 116. Intas Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 117. Intas SWOT Analysis
Table 118. Intas Gabapentin Enacarbil Product and Services
Table 119. Intas Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 120. Global Gabapentin Enacarbil Sales by Manufacturer (2018-2019) (K Units)
Table 121. Global Gabapentin Enacarbil Revenue by Manufacturer (2018-2019) (USD Million)
Table 122. Key Players Gabapentin Enacarbil Sales in China (2018-2019) (K Units)
Table 123. Key Players Gabapentin Enacarbil Sales Market Share in China (2018-2019)
Table 124. Key Players Revenue of Gabapentin Enacarbil in China (2018-2019) (USD Million)
Table 125. Global Gabapentin Enacarbil Sales by Regions (2015-2020) (K Units)
Table 126. Global Gabapentin Enacarbil Sales Market Share by Regions (2015-2020)
Table 127. Global Gabapentin Enacarbil Revenue by Regions (2015-2020) (USD Million)
Table 128. Global Gabapentin Enacarbil Sales and Forecast by Regions (2020-2025) (K Units)
Table 129. Global Gabapentin Enacarbil Sales Market Share by Regions (2020-2025)
Table 130. Global Gabapentin Enacarbil Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 131. Global Gabapentin Enacarbil Revenue Market Share by Regions (2020-2025) (USD Million)
Table 132. North America Gabapentin Enacarbil Sales by Countries (2015-2020) (K Units)
Table 133. North America Gabapentin Enacarbil Sales Market Share by Countries (2015-2020)
Table 134. North America Gabapentin Enacarbil Revenue by Countries (2015-2020) (USD Million)
Table 135. North America Gabapentin Enacarbil Revenue Market Share by Countries (2015-2020)
Table 136. North America Gabapentin Enacarbil Sales by Country (2020-2025) (K Units)
Table 137. North America Gabapentin Enacarbil Sales Market Share by Country (2020-2025)
Table 138. North America Gabapentin Enacarbil Revenue by Country (2020-2025) (USD Million)
Table 139. North America Gabapentin Enacarbil Revenue Market Share by Country (2020-2025)
Table 140. Europe Gabapentin Enacarbil Sales by Countries (2015-2020) (K Units)
Table 141. Europe Gabapentin Enacarbil Sales Market Share by Countries (2015-2020)
Table 142. Europe Gabapentin Enacarbil Revenue by Countries (2015-2020) (USD Million)
Table 143. Europe Gabapentin Enacarbil Revenue Market Share by Countries (2015-2020)
Table 144. Europe Gabapentin Enacarbil Sales by Country (2020-2025) (K Units)
Table 145. Europe Gabapentin Enacarbil Sales Market Share by Country (2020-2025)
Table 146. Europe Gabapentin Enacarbil Revenue by Country (2020-2025) (USD Million)
Table 147. Europe Gabapentin Enacarbil Revenue Market Share by Country (2020-2025)
Table 148. Asia-Pacific Gabapentin Enacarbil Sales by Countries (2015-2020) (K Units)
Table 149. Asia-Pacific Gabapentin Enacarbil Sales Market Share by Countries (2015-2020)
Table 150. Asia-Pacific Gabapentin Enacarbil Revenue by Countries (2015-2020) (USD Million)
Table 151. Asia-Pacific Gabapentin Enacarbil Revenue Market Share by Countries (2015-2020)
Table 152. Asia-Pacific Gabapentin Enacarbil Sales by Country (2020-2025) (K Units)
Table 153. Asia-Pacific Gabapentin Enacarbil Sales Market Share by Country (2020-2025)
Table 154. Asia-Pacific Gabapentin Enacarbil Revenue by Country (2020-2025) (USD Million)
Table 155. Asia-Pacific Gabapentin Enacarbil Revenue Market Share by Country (2020-2025)
Table 156. South America Gabapentin Enacarbil Sales by Countries (2015-2020) (K Units)
Table 157. South America Gabapentin Enacarbil Sales Market Share by Countries (2015-2020)
Table 158. South America Gabapentin Enacarbil Revenue by Countries (2015-2020) (USD Million)
Table 159. South America Gabapentin Enacarbil Revenue Market Share by Countries (2015-2020)
Table 160. South America Gabapentin Enacarbil Sales by Country (2020-2025) (K Units)
Table 161. South America Gabapentin Enacarbil Sales Market Share by Country (2020-2025)
Table 162. South America Gabapentin Enacarbil Revenue by Country (2020-2025) (USD Million)
Table 163. South America Gabapentin Enacarbil Revenue Market Share by Country (2020-2025)
Table 164. Middle East & Africa Gabapentin Enacarbil Sales by Countries (2015-2020) (K Units)
Table 165. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Countries (2015-2020)
Table 166. Middle East & Africa Gabapentin Enacarbil Revenue by Countries (2015-2020) (USD Million)
Table 167. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Countries (2015-2020)
Table 168. Middle East & Africa Gabapentin Enacarbil Sales by Country (2020-2025) (K Units)
Table 169. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Country (2020-2025)
Table 170. Middle East & Africa Gabapentin Enacarbil Revenue by Country (2020-2025) (USD Million)
Table 171. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Country (2020-2025)
Table 172. China Gabapentin Enacarbil Sales by Type (2015-2020) (K Units)
Table 173. China Gabapentin Enacarbil Sales Market Share by Type (2015-2020)
Table 174. China Gabapentin Enacarbil Revenue by Type (2015-2020) (USD Million)
Table 175. China Gabapentin Enacarbil Revenue Market Share by Type (2015-2020)
Table 176. China Gabapentin Enacarbil Sales by Type (2020-2025) (K Units)
Table 177. China Gabapentin Enacarbil Sales Market Share by Type (2020-2025)
Table 178. China Gabapentin Enacarbil Revenue by Type (2020-2025) (USD Million)
Table 179. China Gabapentin Enacarbil Revenue Market Share by Type (2020-2025)
Table 180. Global Gabapentin Enacarbil Sales by Application (2015-2020) (K Units)
Table 181. Global Gabapentin Enacarbil Sales Market Share by Application (2015-2020)
Table 182. Global Gabapentin Enacarbil Revenue by Application (2015-2020) (USD Million)
Table 183. Global Gabapentin Enacarbil Revenue Market Share by Application (2015-2020)
Table 184. Global Gabapentin Enacarbil Price by Application (2015-2020) (US$/Unit)
Table 185. Global Gabapentin Enacarbil Sales by Application (2020-2025) (K Units)
Table 186. Global Gabapentin Enacarbil Sales Market Share by Application (2020-2025)
Table 187. Global Gabapentin Enacarbil Revenue by Application (2020-2025) (USD Million)
Table 188. Global Gabapentin Enacarbil Revenue Market Share by Application (2020-2025)
Table 189. Global Gabapentin Enacarbil Price by Application (2020-2025) (US$/Unit)
Table 190. China Gabapentin Enacarbil Sales by Application (2015-2020) (K Units)
Table 191. China Gabapentin Enacarbil Sales Market Share by Application (2015-2020)
Table 192. China Gabapentin Enacarbil Revenue by Application (2015-2020) (USD Million)
Table 193. China Gabapentin Enacarbil Revenue Market Share by Application (2015-2020)
Table 194. China Gabapentin Enacarbil Sales by Application (2020-2025) (K Units)
Table 195. China Gabapentin Enacarbil Sales Market Share by Application (2020-2025)
Table 196. China Gabapentin Enacarbil Revenue by Application (2020-2025) (USD Million)
Table 197. China Gabapentin Enacarbil Revenue Market Share by Application (2020-2025)
Table 198. Direct Channel Pros & Cons
Table 199. Indirect Channel Pros & Cons
Table 200. Distributors/Traders/ Dealers List
Table 201. Customers of Gabapentin Enacarbil
Table 202. Market Opportunities in Next Few Years
Table 203. Market Risks Analysis
Table 204. Market Drivers
List of Figures
Figure 1. Gabapentin Enacarbil Picture
Figure 2. Global Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Capsule Picture
Figure 4. Tablet Picture
Figure 5. Gabapentin Enacarbil Sales Market Share by Application in 2019
Figure 6. Post-Herpetic Neuralgia (PHN) Picture
Figure 7. Restless Legs Syndrome (RLS) Picture
Figure 8. Others Picture
Figure 9. Global Gabapentin Enacarbil Market Status and Outlook (2015-2025) (USD Million)
Figure 10. Global Gabapentin Enacarbil Sales Growth Rate (2015-2025) (K Units)
Figure 11. Global Gabapentin Enacarbil Sales Market Share by Manufacturer in 2019
Figure 12. Global Gabapentin Enacarbil Revenue Market Share by Manufacturer in 2019
Figure 13. Key Players Gabapentin Enacarbil Revenue Market Share in China in 2019
Figure 14. Global Top 5 Gabapentin Enacarbil Manufacturer Market Share in 2019
Figure 15. Top 3 Gabapentin Enacarbil Players Market Share in China in 2019
Figure 16. Global Gabapentin Enacarbil Revenue Market Share by Regions in 2019
Figure 17. North America Gabapentin Enacarbil Sales YoY Growth (2015-2025) (K Units)
Figure 18. North America Gabapentin Enacarbil Revenue YoY Growth (2015-2025) (USD Million)
Figure 19. Europe Gabapentin Enacarbil Sales YoY Growth (2015-2020) (K Units)
Figure 20. Europe Gabapentin Enacarbil Revenue YoY Growth (2015-2020) (USD Million)
Figure 21. Asia-Pacific Gabapentin Enacarbil Sales YoY Growth (2015-2020) (K Units)
Figure 22. Asia-Pacific Gabapentin Enacarbil Revenue YoY Growth (2015-2020) (USD Million)
Figure 23. South America Gabapentin Enacarbil Sales YoY Growth (2015-2020) (K Units)
Figure 24. South America Gabapentin Enacarbil Revenue YoY Growth (2015-2020) (USD Million)
Figure 25. Middle East & Africa Gabapentin Enacarbil Sales YoY Growth (2015-2020) (K Units)
Figure 26. Middle East & Africa Gabapentin Enacarbil Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. North America Gabapentin Enacarbil Sales Market Share by Country in 2019
Figure 28. North America Gabapentin Enacarbil Revenue Market Share by Country in 2019
Figure 29. United States Gabapentin Enacarbil Market Size and Growth Rate (2015-2025) (USD Million)
Figure 30. Canada Gabapentin Enacarbil Market Size and Growth Rate (2015-2025) (USD Million)
Figure 31. Mexico Gabapentin Enacarbil Market Size and Growth Rate (2015-2020) (USD Million)
Figure 32. Europe Gabapentin Enacarbil Revenue Market Share by Country in 2019
Figure 33. Germany Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 34. United Kingdom Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 35. France Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. Russia Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. Italy Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. Asia-Pacific Gabapentin Enacarbil Sales Market Share by Region 2018
Figure 39. Asia-Pacific Gabapentin Enacarbil Revenue Market Share by Region 2018
Figure 40. China Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Japan Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. Korea Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. India Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Southeast Asia Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Australia Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. South America Gabapentin Enacarbil Sales Market Share by Country in 2019
Figure 47. South America Gabapentin Enacarbil Revenue Market Share by Country in 2019
Figure 48. Brazil Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Argentina Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Saudi Arabia Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Turkey Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Egypt Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. South Africa Gabapentin Enacarbil Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Global Revenue Market Share of Gabapentin Enacarbil by Type in 2019
Figure 55. Global Revenue Market Share of Gabapentin Enacarbil by Application in 2019
Figure 56. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
